Myasthenia gravis (MG), a neuroautoimmune disease characterized by abnormal activation of B and T lymphocytes in the immune system, is caused by autoantibodies against synaptic membrane antigens (mainly nAChR) in neuromuscular junctions (Miranda et al., 2017). The gene discussed is CHRNA4; the disease is myasthenia gravis.